Covered recipient · General Payments record
YONATAN HIRSCH
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2023–2024
$1,540.69
- Reported across 29 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,002.00 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $461.76 | 9 |
| GENZYME CORPORATION | $227.99 | 5 |
| Janssen Biotech, Inc. | $144.83 | 1 |
| Regeneron Healthcare Solutions, Inc. | $105.09 | 1 |
| TACTILE SYSTEMS TECHNOLOGY INC | $34.83 | 1 |
| Lilly USA, LLC | $27.50 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.91 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103922469 | CMS |
| ABBVIE INC. | $97.22 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103922471 | CMS |
| ABBVIE INC. | $20.68 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103922473 | CMS |
| ABBVIE INC. | $21.47 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103922475 | CMS |
| ABBVIE INC. | $18.69 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103922477 | CMS |
| ABBVIE INC. | $24.19 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103922479 | CMS |
| ABBVIE INC. | $115.56 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103922481 | CMS |
| ABBVIE INC. | $120.24 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103922483 | CMS |
| ABBVIE INC. | $20.80 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103922485 | CMS |
| GENZYME CORPORATION | $35.87 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139804400 | CMS |
| GENZYME CORPORATION | $39.08 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139804444 | CMS |
| GENZYME CORPORATION | $59.84 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139804502 | CMS |
| GENZYME CORPORATION | $59.84 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139804528 | CMS |
| GENZYME CORPORATION | $33.36 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139804530 | CMS |
| Janssen Biotech, Inc. | $144.83 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078578536 | CMS |
| Lilly USA, LLC | $27.50 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135455771 | CMS |
| Regeneron Healthcare Solutions, Inc. | $105.09 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114069928 | CMS |
| Tactile Systems Technology Inc | $34.83 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082376411 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.